Association of OAS1 rs10774671 Polymorphism with COVID-19 severity in a Pakistani cohort
Rawal Medical Journal · 2026 · 51 (4) · 937
DOI: 10.5455/rmj.20260407052803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rawal Medical Journal, 2026. Verfasst von Ambreen Zahra und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To assess the evidence for the OAS1 rs10774671 genetic variant association with COVID-19 severity and associated risk factors in the Pakistani population. Methodology: In this analytical cross-sectional study, 200 PCR-confirmed COVID-19 patients were genotyped by TaqMan real-time PCR, with 6% of samples validated by Sanger sequencing. Associations were assessed using Chi-square tests and multivariable logistic regression adjusted for age, sex, BMI, and comorbidities.
Results
Participants had AA (75), AG (71), and GG (54) genotypes. The AA genotype demonstrated nearly a 3-fold higher likelihood of developing severe COVID-19 compared to the mild/moderate group (OR=2.99; 95% CI=1.30–6.86; p=0.0073). Among 143 active COVID-19 patients (71 severe and 72 mild/moderate), higher BMI (aOR=1.20 per kg/m², 95% CI: 1.1–1.32; p
Zitieren
APA
Zahra, A., Khan, S., Shamim, A., & Arshad, M. (2026). Association of OAS1 rs10774671 Polymorphism with COVID-19 severity in a Pakistani cohort. Rawal Medical Journal, 51(4), 937. https://doi.org/10.5455/rmj.20260407052803
Vancouver
Zahra A, Khan S, Shamim A, Arshad M. Association of OAS1 rs10774671 Polymorphism with COVID-19 severity in a Pakistani cohort. Rawal Medical Journal. 2026;51(4):937. doi:10.5455/rmj.20260407052803
BibTeX
@article{Zahra2026,
author = {Zahra, Ambreen and Khan, Sultan and Shamim, Amen and Arshad, Muhammad},
title = {Association of OAS1 rs10774671 Polymorphism with COVID-19 severity in a Pakistani cohort},
journal = {Rawal Medical Journal},
year = {2026},
volume = {51},
number = {4},
pages = {937},
doi = {10.5455/rmj.20260407052803}
}
EUVIMED